A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia

Clinical trial NCT04964557 · COMPLETED

Trial details

NCT number: NCT04964557
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperlipidaemia

Start date: 2021-07-07
Primary completion: 2022-07-15
Enrollment: 411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.